SEC 13F Intelligence

Trv GP III, LLC / PLRX

Trv GP III, LLC’s Pliant Therapeutics Inc Position

Does Trv GP III, LLC own Pliant Therapeutics Inc (PLRX)? Yes — 339.2K shares worth $6M (+100.00% of its 13F portfolio) as of Q4 2023.

Position Value
$6M
Q4 2023
Shares
339.2K
% of Portfolio
+100.00%
Quarters Held
15
currently held

Position History PLRX

Reported value by quarter
Q2 ’20: $190MQ2 ’20Q3 ’20: $132MQ4 ’20: $133MQ4 ’20Q1 ’21: $230MQ2 ’21: $170MQ2 ’21Q3 ’21: $99MQ4 ’21: $79MQ4 ’21Q1 ’22: $41MQ2 ’22: $47MQ2 ’22Q3 ’22: $80MQ4 ’22: $36MQ4 ’22Q1 ’23: $49MQ2 ’23: $6MQ2 ’23Q3 ’23: $6MQ4 ’23: $6MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023339.2K$6M+100.00%
Q3 2023339.2K$6M+100.00%
Q2 2023339.2K$6M+33.71%
Q1 20231.84M$49M+58.97%
Q4 20221.84M$36M+27.86%
Q3 20223.84M$80M+35.02%
Q2 20225.84M$47M+19.13%
Q1 20225.84M$41M+11.11%
Q4 20215.84M$79M+19.73%
Q3 20215.84M$99M+18.71%
Q2 20215.84M$170M+29.69%
Q1 20215.84M$230M+29.05%
Q4 20205.84M$133M+11.39%
Q3 20205.84M$132M+11.11%
Q2 20205.84M$190M+27.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP III, LLC’s full portfolio or all institutional holders of PLRX.